The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Age Related Macular Degeneration (AMD) Market Research Report 2025
Synopsis
The global Age Related Macular Degeneration (AMD) market was valued at US$ 7725.7 million in 2023 and is anticipated to reach US$ 11400 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration (AMD).
Report Scope
The Age Related Macular Degeneration (AMD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age Related Macular Degeneration (AMD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age Related Macular Degeneration (AMD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Segment by Type
Wet AMD
Dry AMD
Segment by Application
Men
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Age Related Macular Degeneration (AMD) market was valued at US$ 7725.7 million in 2023 and is anticipated to reach US$ 11400 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated.
This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration (AMD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration (AMD).
Report Scope
The Age Related Macular Degeneration (AMD) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Age Related Macular Degeneration (AMD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Age Related Macular Degeneration (AMD) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Segment by Type
Wet AMD
Dry AMD
Segment by Application
Men
Woman
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Age Related Macular Degeneration (AMD) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2019-2030)
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Global Age Related Macular Degeneration (AMD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2019-2024)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2025-2030)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2019-2024)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2019-2024)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2023
3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2019-2024)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2025-2030)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2019-2024)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
6.2 North America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2019-2030)
7.2 Europe Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2019-2030)
8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2019-2024)
8.4 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2019-2030)
9.2 Latin America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
9.4 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2019-2030)
10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2019-2024)
10.4 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Detail
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.2.5 F. HoffmannLa Roche Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Detail
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.3.5 Regeneron Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Valeant
11.5.1 Valeant Company Detail
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.5.5 Valeant Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2019-2024)
11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
